The QualityStocks Daily Tuesday, June 5th, 2018

Today's Top 3 Investment Newsletters

PennyStockScholar (AMRH) +92.55%

TraderPower (VSQTF) +23.35%

CannabisNewsWire (MCOA) +22.06%

The QualityStocks Daily Stock List

Telkonet, Inc. (TKOI)

SmallCapVoice, RedChip, FeedBlitz, Alternative Energy, Stock News Now, CoolPennyStocks, BullRally, Stock Rich, and HotOTC reported previously on Telkonet, Inc. (TKOI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Telkonet, Inc. provides unique intelligent automation platforms at the vanguard of the Internet of Things (IoT) space. The Company helps commercial audiences better manage operational costs via its EcoSmart intelligent automation platform. Vertical markets that benefit from EcoSmart products include hospitality, education, military, government, healthcare and multiple dwelling housing. Telkonet has its corporate headquarters in Waukesha, Wisconsin.

Telkonet’s EcoSmart intelligent automation platform is supported by a full-suite of IoT-connected devices. These devices provide in-depth energy usage information and analysis. This allows building operators to cut energy expenses. The Company has successfully deployed more than 600,000 devices across greater than 3,000 properties.

The foundation of Telkonet’s EcoSmart platform is on four distinct pillars. One pillar is the EcoSmart suite of IoT products - connected devices. A second is EcoCentral – the Company’s cloud-based EMS dashboard. The third pillar is EcoSmart Mobile – Telkonet’s smart device app. The fourth pillar is EcoCare - its service and support subscription. The Company’s platform integrates with a broad spectrum of products serving varied markets.

This past March, Telkonet announced that it, and reseller partner, Legend Energy Advisors, deployed Telkonet's innovative EcoSmart energy-management platform at Murray Hill Marquis in New York, New York, with EcoSmart Mobile application control. EcoSmart Mobile gives tenants easy control of their apartment's comfort. This is while providing the property major opportunities for energy savings.

EcoSmart takes advantage of occupancy-sensing thermostats, stand-alone sensors, plugs, light switches, and top third-party integrations and automation, to intelligently control energy utilization and create immersive user experiences.

Today, Telkonet announced it has teamed with Volara, the first voice-based hotel guest engagement solution, which turns voice into a strong hospitality business tool. Together, they now offer a hospitality environment in which guests can use voice commands to control intelligent in-room devices and platforms to set scenes within their own hotel rooms. These scenes can incorporate one device or numerous different devices to create the exact environment that a hotel guest requests.

Hotel operators can configure ‘scenes’ and ‘commands’, which will enable guests to select their comfort level and environment. These settings will be customized to the EcoSmart Platform devices deployed and the capabilities provided within the hotel.

Telkonet, Inc. (TKOI), closed Tuesday's trading session at $0.115, up 4.36%, on 61,637 volume with 14 trades. The average volume for the last 60 days is 67,974 and the stock's 52-week low/high is $0.0902/$0.20.


Command Center, Inc. (CCNI)

Zacks, Wall Street Resources, Netcom, OnTheMar, Investor Guide, William Velmer, FeedBlitz, and SmallCapVoice reported on Command Center, Inc. (CCNI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Command Center, Inc. is a national provider of on-demand and temporary staffing solutions. The Company provides flexible on-demand employment solutions to businesses in the United States. This is primarily in the areas of light industrial, hospitality, as well as event services. The Company has 67 field offices in 22 States. Command Center is based in Denver, Colorado. The Company lists on the OTC Markets Group’s OTCQB.

Command Center provides employment for roughly 33,000 field team members working for more than 3,200 clients. Its specialty is providing properly skilled workers for any size project on an ‘on demand’ basis. The Company’s Command Staffing® has substantial experience matching businesses with highly qualified job seekers.

Concerning Command Trades (sm) Services, Command Center offers its commercial, industrial, and residential skilled trades division. The Company’s qualified, skilled trades-people include automotive technicians, carpenters, electricians, HVAC, drivers, plumbers, pipefitters, welders, builders, and more.

Command Center also has its Command Movers (sm) Services. The Company provides properly trained movers for relocation projects, which are covered under a workers’ compensation policy.

In addition, Command Center has its Command Hospitality® Services. The Company trains and places temporary and/or permanent employees within the hospitality sector. Command Center provides servers, host/hostesses, cooks, bartenders, laundry workers, cashiers, stand workers, front desk personnel, housekeepers, maintenance, and janitorial workers for clients of all sizes.

Concerning its Command Events(sm) Services, Command Center maintains relationships with trained event workers that are ‘on call’. The Company’s branches quickly assemble event crews.

Command Center previously acquired substantially all the assets of Hancock Staffing. Hancock Staffing provides services in the same general market segments that Command Center presently operates. Hancock Staffing operated branches in Little Rock, Arkansas, and Oklahoma City, Oklahoma.

In May, Command Center reported financial results for Q1 ended March 30, 2018. For Q1 2018 in comparison to the year-ago quarter Revenue increased to $22.5 million versus $22.3 million. Gross Margin was 24.9 percent in comparison to 25.7 percent.

Net Loss was $1.2 million, or $(0.24) per diluted share, versus Net Income of $0.2 million, or $0.04 per diluted share. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) remained at $0.4 million.

Mr. Rick Coleman, Command Center President and Chief Executive Officer, said, “Our first quarter reflected strong revenue across many of our branches, which was offset by some one-time larger national accounts project work in 2017.”


Command Center, Inc. (CCNI), closed Tuesday's trading session at $5.70, up 0.88%, on 28,300 volume with 18 trades. The average volume for the last 60 days is 9,596 and the stock's 52-week low/high is $3.50/$6.50.


Reliq Health Technologies, Inc. (RQHTF)

Stockhouse, Morningstar, MarketWatch, Streetwise Reports, InvestorsHub, Barron’s, OTC Markets, GuruFocus, Zacks, FinancialPost, Equities, Business Insider, Barchart, Investors Hangout, Penny Stock Tweets, Capital Cube, EmergingGrowth, and reported on Reliq Health Technologies, Inc. (RQHTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Reliq Health Technologies, Inc. is a technology company centered on creating unique mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare. Its strong iUGO Care platform supports care coordination and community-based healthcare.

The Company previously went by the name Moseda Technologies, Inc. It changed its corporate name to Reliq Health Technologies, Inc. in May of 2016. Reliq Health Technologies has its head office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care permits complex patients to receive high quality care at home. This improves health outcomes, enhances quality of life for patients and families, and lessens the cost of care delivery.

Reliq Health Technologies’ platform provides automated remote patient monitoring in the home. It supports secure communication between all members of the patient’s circle of care. The Company has developed a novel SaaS (Software-as-a-Service) solution for the $30 Billion Community Healthcare market.

In essence, the iUGO Care platform turns the patient’s home into a “virtual hospital ward” employing an automated two-way voice, proximity sensors, and biometric monitoring devices. Data collected in the home is automatically uploaded to the iUGO Care secure cloud. There it is available to all members of the patient’s circle of care, with automated alerts if a patient’s condition starts to deteriorate. The iUGO Care platform improves medication adherence.

Reliq Health Technologies closed 2017 with more than 6,000 paid subscribers using its iUGO Care chronic care management, remote patient monitoring and telemedicine platform. This represents recurring monthly revenue of over US$300,000/month. Therefore, December 2017 was Reliq’s first month of profitability.

In December 2017, Reliq Health Technologies announced that it signed an agreement with B Golden Care Services, LLC in McAllen, Texas. This agreement is to implement Reliq’s iUGO Care chronic care management platform for B Golden Care Services’ 1,000 complex continuing care patients. The expectation is that onboarding of patients will commence in late Q1 of 2018.

Last month, Reliq Health Technologies announced that it signed an agreement with True Life Home Health LLC in Texas to provide Reliq’s iUGO Care chronic care management, remote patient monitoring and telemedicine platform to its greater than 2,000 home care clients. This contract will produce more than $1,200,000 USD in gross recurring annual Revenue at full deployment with patient enrolment starting this month.

B Golden Care Services is a new and growing chronic care management agency in Southern Texas.  It provides services to patients in the home setting, supporting patients aging in place, improving medication adherence, and empowering patients to proactively manage their own health.

Reliq Health Technologies, Inc. (RQHTF), closed Tuesday's trading session at $1.09, up 1.79%, on 52,505 volume with 43 trades. The average volume for the last 60 days is 47,878 and the stock's 52-week low/high is $0.076/$2.0297.


Sunset Island Group, Inc. (SIGO)

MicrocapVoice, PennyStockSpy, OTCPicks, and 007 Stock Chat reported earlier on Sunset Island Group, Inc. (SIGO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business space. The Company concentrates on providing a licensed manufacturing facility to clients for producing products, including oils and edibles. Sunset Island Group has its corporate office in San Clemente, California.

The Company’s vision is to establish a fully integrated business, which provides turnkey solutions to the medical cannabis industry. Its primary emphasis is on providing a licensed facility where companies can manufacture and produce their products. In addition, Sunset Island will provide distribution for companies via an established network of dispensaries.

Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis each year.

Sunset Island announced last year that it initiated development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit.

Sunset Island will continue to develop products that will address the demands in the worldwide dietary supplements market. This market is targeted to soon reach greater than $200 billion. The product will undergo development by a trained French Chef with more than two decades of experience in Product Development and Food Production.

Sunset Island Group is performing a retrofit to its current grow space that will considerably increase the amount of cannabis product produced with each harvest. Furthermore, the Company announced in November 2017 that it commenced an aggressive expansion of its cannabis product line.

The Company’s retro fit is two phases. Phase 1 is the retro fit of the present greenhouse operations. Phase 2 is the constructing of a new greenhouse on its bare land or retrofitting another greenhouse on the property.

The aim of the retro fit for Phase 1 is to increase the growable space in the current greenhouse to about 22,000 (with a vertical grow) with roughly 85 percent being canopy space (or around 19,000 square feet). The Company's objective is to yield 0.08-0.10 pounds per growable space and to have five harvests.

Sunset Island Group has received its temporary licenses from the State of California for Distribution, Cultivation and Manufacturing. The licenses are for Adult Use (Recreational) and Medicinal. The licenses permit Sunset Island to sell and transport its own product to dispensaries across California.

The manufacturing license allows it to start manufacturing products such as vape cartridges, edibles, as well as extracts. At present, Sunset Island is in the process of converting one of its cold storage rooms into a clean room to commence manufacturing these products.

Sunset Island Group, Inc. (SIGO), closed Tuesday's trading session at $0.799, up 7.97%, on 2,401 volume with 5 trades. The average volume for the last 60 days is 43,744 and the stock's 52-week low/high is $0.10/$3.30.


Cadus Corporation (KDUS)

OTC Markets, InvestorsHub, Morningstar, MarketWatch, CorporateInformation, Capital Cube, The Street and Greenbackd reported on Cadus Corporation (KDUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cadus Corporation is in the business of buying individual homes and individual residential lots, renovating or constructing on them, and reselling them. To date, it has mainly centered its real estate activities in the State of Florida. Established in 1992, Cadus has its corporate headquarters in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Cadus’ portfolio includes Sunset Island II; Atlantic Island; Town of Surfside; Sans Souci Estates I; Sans Souci Estates II; Stillwater; as well as Biscaya Island. Sunset Island II features a two-story open-concept layout. It includes a spacious open kitchen, an oversized master suite, 11’6 ceilings, and a pool. It is in South Beach’s exclusive Sunset Island II gated community.

Atlantic Island is on Atlantic Isle. It is an elegant 3-bedroom new construction to-be-built waterfront home. It features a distinguished contemporary architectural design.

The Town of Surfside in Surfside Florida is a modern-style to-be-constructed home. It is set over a creative two-story open-concept layout. This includes a sleek kitchen, 11’6 ceilings, an oversized master suite, and also a family room.

Sans Souci are premier waterfront lots. They provide the setting for these to-be-built new construction masterpieces. They are open-concept homes that feature an over-sized master suite, designer finishes in the kitchen and bathrooms, and wide bay views from every angle of the homes.

Stillwater in Miami Beach, Florida, is in the gated community of Stillwater Drive in a modern to-be-built new construction home. This two-story open-concept home features designer kitchens and bathrooms. It offers wide bay and Indian Creek Island views.

Biscaya Island in Miami Beach is positioned along immaculate private waterfront on Biscaya Island. The new construction to-be-built home is crafted with a contemporary exterior and an open-concept layout.

Last month, Cadus announced that it entered into an Agreement and Plan of Merger with Starfire Holding Corporation, an affiliate of Carl C. Icahn and an affiliate of Cadus’ controlling stockholders, Barberry Corp. and High River Limited Partnership (High River collectively). Starfire will acquire Cadus.

With this Merger Agreement, upon completion of the transaction, all outstanding shares of Cadus common stock not owned by High River or its affiliates will be converted into the right to receive $1.61 per share in cash, without interest.

Cadus Corporation (KDUS), closed Tuesday's trading session at $1.59, up 0.63%, on 200 volume with 2 trades. The average volume for the last 60 days is 34,064 and the stock's 52-week low/high is $0.92/$1.61.


Zynex, Inc. (ZYXI)

FeedBlitz, Zacks, SmallCapVoice, SmarTrend Newsletters, BUYINS.NET, FNNO Newsletters, Daily Markets, and TaglichBrothers reported previously on Zynex, Inc. (ZYXI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company headquartered in Englewood, Colorado. It specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. Furthermore, the Company is developing a new blood volume monitor (non-invasive Blood Volume Monitor, CM-1500) for use in hospitals and surgery centers. Zynex lists on the OTC Markets’ OTCQB.

The Company believes that its non-invasive Blood Volume Monitor, CM-1500, will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.

Zynex’s product lines are totally developed, Food and Drug Administration (FDA)-cleared, and commercially sold around the world. Zynex engineers, manufactures, markets, and sells its own design of medical devices in three subsidiaries.

Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets.

Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. In addition, the Company markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.

Zynex has added new products to its portfolio. These include JetStream Hot/Cold Therapy, Aspen LSO Backbracing and Comfortrac cervical traction. All of these products are targeted at treating acute and chronic pain without side-effects.

Zynex announced this past February the introduction of the NeuroMove device into the Company’s growing direct sales force in the United States market. The design of the NeuroMove™ device is to assist stroke survivors in regaining movement using the brain's ability to rewire itself, also known as "neuro-plasticity".

Recently, Zynex announced that ColoradoBiz Magazine recognized Zynex as a Top100 Public Company in its May/June 2018 issue. The Company was ranked 83rd on 2017 Revenue of $23.4 million. This is up from 90th in 2016 on $13.3 million in Revenue. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) in 2017 was $9.5 million.

Zynex, Inc. (ZYXI), closed Tuesday's trading session at $3.75, up 9.65%, on 47,168 volume with 112 trades. The average volume for the last 60 days is 21,171 and the stock's 52-week low/high is $0.375/$5.50.


BioLargo, Inc. (BLGO)

Tiny Gems, TopPennyStockMovers, Stock News Now, Promotion Stock Secrets, SECFilings, FeedBlitz, Equities, SmallCapVoice, and Penny Sleuth reported earlier on BioLargo, Inc. (BLGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioLargo, Inc. delivers practical solutions for clean water, clean air, and advanced wound care. The Company delivers technology-based products that help solve some of the world’s most important problems that threaten water, food, agriculture, healthcare and energy. BioLargo is an innovator of sustainable science and technology and a full-service environmental engineering company. BioLargo is based in Westminster, California.

The Company’s subsidiary is BioLargo Water, Inc. BioLargo Water showcases the Advanced Oxidation Systems, including its AOS Filter. This is a product in development specifically designed to eliminate common, troublesome, and toxic contaminants in water in a fraction of the time and expense of current technologies.

The BioLargo® AOS Filter is BioLargo’s featured AOS Filter system. The BioLargo® AOS Filter extends the life of filtration systems, lessens corrosion, and conserves chemistry. The Company’s Canadian subsidiary, BioLargo Water, Inc. initiated a prototype development project for its AOS Filter technology.

The BioLargo® AOS Filter facilitates continuing and scalable treatment with maximum efficiency utilizing GRAS components to convert contaminates to H2O and CO2. It destroys hard to get contaminates and disinfects fast and completely. The BioLargo® AOS Filter is complementary with numerous filter systems.

BioLargo’s subsidiary, Clyra Medical Technologies, Inc., focuses on advanced wound care management. BioLargo also owns a 50 percent interest in the Isan System. This system was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project, now under license to Clarion Water, Inc.

BioLargo’s subsidiary, Odor-No-More, Inc., features award-winning products serving the pet, equine, military supply, as well as consumer markets. This includes the Nature's Best Solution® and Deodorall® brands.

CupriDyne® Clean Industrial Odor Eliminator is made by Odor-No-More. Odor-No-More has signed what are known as national purchasing or national supply agreements with three top U.S. waste handling enterprises.

Recently, BioLargo announced that its Canadian subsidiary received a commitment of up to CA$235,000 for a pre-commercial pilot project for its Advanced Oxidation System (AOS) for on-site treatment of poultry processing wastewater at a potential client’s poultry processing facility.

This funding will be provided by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). With this support, BioLargo’s AOS has received roughly CA$500,000 in total contributions so far from the NRC IRAP.

BioLargo, Inc. (BLGO), closed Tuesday's trading session at $0.40, down 9.09%, on 402,334 volume with 117 trades. The average volume for the last 60 days is 68,657 and the stock's 52-week low/high is $0.204/$0.70.


Vegalab, Inc. (VEGL)

OTC Markets, Capital Cube, Barchart, MarketWatch, InvestorsHub, TradingView, Simply Wall St, YCharts, Investors Hangout, Stockwatch, BusinessInsider, PennyStockHub, and InvestingNewsAlerts reported on Vegalab, Inc. (VEGL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. Its products support a healthy soil biome. Moreover, they are cost competitive with synthetic chemicals that do just the opposite. The Company previously went by the name HPC Acquisitions, Inc. It changed its name to Vegalab, Inc. in November of 2017. Vegalab has its corporate office in North Palm Beach, Florida.

The Company’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Every Vegalab product strives to boost productivity and lessen waste. Vegalab’s formulas and processes are the result of years of biological research and development, producing eco-safe, all-natural products.

Vegalab’s products include Biocontrol Agents, Insecticides, Fungicides, Soil Inoculants, and Fertilizers. All of the Company’s oil-based products go through a process of micronization. This gives these oils the ability to cover a larger surface area and enabling deeper penetration into the crevices of plants, insects, and pathogens. The minute pores and filaments in the plant absorb Vegalab’s products quicker versus conventional oils.

Recently, Vegalab US announced the purchase of substantially all of the assets related to a produce packaging business in Tulare County, California. This acquisition closed on October 18, 2017. It comprised the purchase of roughly 11 acres of real property and 30,000 sq. ft. of buildings from M & G Farms, Inc. (a California corporation) and all of the equipment, inventory, customers, suppliers, contract rights, and intangible property from M&G Packing, Inc., the California Corporation that operated the Business.

Last month, Vegalab US reported, in a filing with the Securities and Exchange Commission (SEC), that it exercised an option to acquire The Agronomy Group, LLC. The Agronomy Group (TAG) is located in Tulare County, California. It is a producer and distributor of environmentally friendly agrochemicals.

TAG is Vegalab's foremost U.S. sales organization for Vegalab products. Therefore, this acquisition allows Vegalab to expand its internal marketing capability. In addition, TAG distributes other products. Consequently, this acquisition increases Vegalab’s scope of product offerings.

Last week, Vegalab announced that on January 7, 2018, it entered into a Master Distribution Agreement with Stanislaus Farm Supply, a member of Winfield United, as a master distributor for California and Nevada. The effective date of the agreement is November 1, 2017. This coincides with Stanislaus' first purchases of Vegalab products.

The initial term of the distribution agreement is five years. This agreement provides for a yearly minimum volume of product purchases with a total yearly contract value of roughly $13,000,000.

Furthermore, last week, Vegalab announced the successful trials of its Pollen Boost product and initial first orders of Pollen Boost for delivery in early February from Stanislaus Farm Supply, Buttonwillow Warehouse Company, and Mid Valley Agricultural Services, Inc.  The successful trials and first orders for Pollen Boost are a culmination of the Company’s emphasis on market leading, Earth friendly products, which give farmers a considerable Return on Investment (ROI).

Vegalab, Inc. (VEGL), closed Tuesday's trading session at $3.30, up 1.54%, on 1,980 volume with 5 trades. The average volume for the last 60 days is 1,322 and the stock's 52-week low/high is $0.65/$5.24.


K92 Mining, Inc. (KNTNF)

TradeKing, Investors Hangout, Future Money Trends, Stockhouse, MarketWatch, InvestorsHub, Barchart, OTC Markets, Morningstar, GuruFocus, Marketwired, and Resource Stock Digest reported earlier on K92 Mining, Inc. (KNTNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

K92 Mining, Inc. engages in the exploration and development of mineral deposits in Papua New Guinea. The Company has commenced gold production from the Irumafimpa Gold Deposit that together with the Kora Gold Deposit is part of its Project located in the Eastern Highlands province of Papua New Guinea. K92 Mining is based in Vancouver, British Columbia. The Company’s shares trade on the OTCQB.

Kainantu highlights include existing infrastructure. This includes underground mine development, a mill processing facility, staff housing, a licensed tailings pond, office space, paved access roads, and a reliable hydro supply by way of a dedicated power line. The Kainantu property covers a total area of approximately 410km2.

Additionally, Kainantu highlights include USD $41.3 million invested in exploration drilling and definition drilling. The present resource estimate is based on 78,935m of drilling through 767 drill holes.

Furthermore, the Process Mill earlier successfully treated the initial batch of underground ore delivered from Irumafimpa, with concentrate now produced. There is a major opportunity to expand known zones of mineralization, and for the discovery of new ore bodies.

Last week, K92 Mining announced that it achieved and declares commercial production, effective February 1, 2018, at its Kainantu Gold Mine in Papua New Guinea. Production for the month of January 2018 surpassed 2,700 ozs gold equivalent (2,500 ozs gold).

The Company defined commercial production as having started stope production underground, attaining a minimum of 60 percent of designed gold production and a minimum of 90 percent of designed metal recovery from the process plant over a 30 day period.

These metrics were met during January 2018. K92 Mining expects them to be maintained going forward. As a result, it has declared commercial production effective February 1, 2018.

In addition, last week, K92 Mining announced that it intersected numerous intervals of high grades of gold in drill hole KMDD0049, which is a drill hole on the most southerly line undergoing drilling from diamond drill cuddy 2 (DDC2) orientated 25o upwards, above the present working level.

Included within the results is the highest grade and best intersection the Company has attained from Kora vein K2, being 6.8 m (4.75 true width) @ 56.45 g/t AuEq along continuing high grades in Kora vein K1, being 5.6m (3.27 true width) @ 41.71 g/t AuEq.

Further to these wide intervals of high grade, an intersection into a cross cutting link structure designated Kora KL2 returned an assay of 2.8m (1.96 true width) @ 13.33 g/t AuEq.

K92 Mining, Inc. (KNTNF), closed Tuesday's trading session at $0.57, up 1.46%, on 137,995 volume with 58 trades. The average volume for the last 60 days is 139,716 and the stock's 52-week low/high is $0.3095/$0.71.


UEX Corporation (UEXCF)

OTC Markets, Stockhouse,, Barchart, Geology for Investors, Investing News, Wolcott Daily, Morningstar, Stockwatch, MarketWatch, Barron’s, Junior Mining Network, and OTC Dynamics reported on UEX Corporation (UEXCF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

UEX Corporation is a junior exploration company with a diverse portfolio of projects in Saskatchewan’s Athabasca Basin. Since its establishment, the Company has made significant advancements in the discovery and development of existing and new uranium deposits in the Athabasca Basin. UEX has its head office in Saskatoon, Saskatchewan. The Company also has a satellite office in Vancouver, British Columbia.

UEX’s foundation is substantial existing uranium resources. Furthermore, the Company is exploring the West Bear Cobalt-Nickel Prospect by way of its 100 percent owned subsidiary CoEx Metals Corporation. The West Bear Project was formerly part of UEX’s Hidden Bay Project. It contains the West Bear Cobalt-Nickel Prospect and the West Bear Uranium Deposit.

Additionally, UEX is increasing its resources at Christie Lake. The new Orora Discovery tested the Company’s first identified new target on this project. On the whole, UEX has a large inventory of historical mineralized holes that can undergo follow up to make new discoveries. In essence, the Company’s focus is on growing Christie Lake Uranium and enhancing Shareholder value through Cobalt.

UEX is involved in 17 uranium projects, including seven that are 100 percent owned and operated by the Company, one joint venture (JV) with Orano Canada, Inc. that is 90.1 percent owned by UEX and is under option to and operated by ALX Uranium, and eight JVs with Orano, one JV with Orano and JCU (Canada) Exploration Company Limited, which are operated by Orano, and one project (Christie Lake) under option from JCU (Canada) Exploration Company Limited and operated by UEX.

UEX is now advancing several uranium deposits in the Athabasca Basin. These include the Christie Lake deposits, the Kianna, Anne, Colette and 58B deposits at its currently 49.1 percent-owned Shea Creek Project, the Horseshoe and Raven deposits on its 100 percent-owned Horseshoe-Raven Development Project, and the West Bear Uranium Deposit positioned on its 100 percent-owned West Bear Project.

In early May, UEX, via CoEX Metals, announced that the fourth tranche of assay results were received for the final 15 holes from the Phase 1 winter drilling program on the West Bear Cobalt-Nickel Prospect. The Company completed 41 holes totaling 4,457 m on its West Bear Cobalt-Nickel Prospect situated on the West Bear Project with the aim of expanding the size of the cobalt and nickel mineralized zone.  Phase 1 drilling activities at West Bear have now concluded.

UEX Corporation (UEXCF), closed Tuesday's trading session at $0.2182, up 3.27%, on 75,074 volume with 8 trades. The average volume for the last 60 days is 27,506 and the stock's 52-week low/high is $0.1116/$0.3131.


American Resources Corporation (AREC)

OTC Markets, Penny Stock Hub, Stockwatch, MarketWatch, OiladGas360, Barchart, Stockhouse, Simply Wall St, NetworkNewsWire, InvestorsHangout, Coal Zoom, and Street Insider reported on American Resources Corporation (AREC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Resources Corporation engages in diversified energy services. This includes mining, processing, and logistics. The Company’s principal emphasis is on traditional energy sources such as coal and oil and gas. The Company previously went by the name NGFC Equities, Inc. It changed its name to American Resources Corporation in February of last year. American Resources has its corporate office in Fishers, Indiana.

The Company plans to expand its business through continuing to develop its currently leased properties and further expanding its processing and logistics business. It also plans to expand its business through the pursuit of strategic acquisitions.

A diversified natural resources company, American Resources concentrates on acquiring and developing low cost, asset rich operations. The Company focuses on the extraction, processing, storage and distribution of raw material for industrial purposes.

The markets that American Resources focuses on include coal operations; LNG (Liquefied Natural Gas) storage and distribution; oil and natural gas production & reserves; and new energy technologies. Regarding coal operations, the Company’s focus is on vertically integrated coal operations. This includes coal extraction, coal wholesaling, as well as distribution.

This past April, American Resources announced that, via its wholly-owned subsidiary Quest Energy, Inc. and McCoy Elkhorn Coal LLC, it entered into an agreement to acquire certain coal assets from Empire Coal Processing, LLC. This includes the currently operating PointRock Surface Mine in Phelps, Pike County, Kentucky. With this agreement, McCoy Elkhorn Coal immediately assumes operational control of the PointRock Mine and the associated leases, permits, government approvals, reclamation bonds, and equipment.

Recently, American Resources announced that through Quest Energy and Knott County Coal LLC, it entered into an agreement to acquire an active surface mining operation centered on re-mining a coarse disposal area in Wayland, Floyd County, Kentucky. With this agreement, Knott County Coal immediately assumes ownership of all permits, leases, government approvals, and reclamation bonds associated with the Wayland, Kentucky refuse area.

American Resources, via Quest Energy and Deane Mining LLC, recently started operations at its Razorblade Surface mine in Letcher County, Kentucky. This is American Resources fifth mine brought into production in the last two years since acquiring and restructuring an asset base throughout the industry's most recent downturn to operate on a more efficient cost structure.

Upon being fully operational, American Resources expects Razorblade to contribute as much as 26,000 clean tons of high-grade PCI and thermal coal monthly and enable them to expand coal sales to meet customers' demands since restarting its Access Energy mine at Deane Mining in September of 2017.

American Resources Corporation (AREC), closed Tuesday's trading session at $1.05, even for the day, on 325,977 volume with 2,097 trades. The average volume for the last 60 days is 420,571 and the stock's 52-week low/high is $8.05/$23.70.


Thunder Energies Corporation (TNRG)

InvestorsHub, The Street, Stockwatch, The Stock Radio, Marketbeat, WalletInvestor, InvestorPlace, The Silicon Review, and Market Exclusive reported on Thunder Energies Corporation (TNRG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Thunder Energies Corporation focuses on the manufacture, sale, and service of diverse technologies in the U.S. The Company previously went by the name Thunder Fusion Corporation. It changed its name to Thunder Energies Corporation in May of 2014. The Company lists on the OTC Markets Group’s OTCQB. Thunder Energies has its corporate headquarters in Tarpon Springs, Florida.

Thunder Energies markets its technologies through three divisions. These are Nuclear Instruments, Optical Instruments, and Combustion Equipment. Regarding the Division of Nuclear Equipment, the production, promotion, sale and service of the Santilli Thermal Neutron Source is founded on a novel synthesis of the neutron from a hydrogen gas (international patent pending).

Concerning the Division of Combustion Equipment, its focus is the production, promotion, sale and service of the novel HyperFurnace that attains the complete combustion of fossil fuels and an enhanced energy output (patented and international patents pending).

Pertaining to the Division of Optical Equipment, its emphasis is the production, promotion, sale and service of pairs of Galileo telescopes with convex lenses to detect matter-galaxies & Santilli telescopes with concave lenses to detect antimatter-galaxies (international patent pending).

Last month, Dr. Ruggero M. Santilli, Chief Executive Officer and Chief Scientist of Thunder Energies announced new advances for the model of Directional Neutron Source developed in the United States and tested in nuclear facilities in Europe for the detection in airports of nuclear material that may be concealed in suitcases, the detection and concentration of precious metals in mining operations, various military uses, and other applications.

Dr. Santilli stated, "I am pleased to report [that] the development in collaboration with our European partners of a basically new Directional Neutron Source, namely, an equipment capable of producing on demand a flux of low energy neutrons synthesized from a hydrogen gas predominantly in a selected direction.”

Yesterday, Thunder Energies announced that Dr. Santilli was knighted on May 31, 2018 by the President of Italy, Sergio Mattarella, for his scientific and industrial discoveries at a ceremony organized by the Italian Counsul in Miami Dott.

Thunder Energies Corporation (TNRG), closed Tuesday's trading session at $0.016, down 46.67%, on 2,530,394 volume with 71 trades. The average volume for the last 60 days is 138,667 and the stock's 52-week low/high is $0.012/$0.30.


The QualityStocks Company Corner

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

MARIJUANA COMPANY OF AMERICA INC. (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s hempSMART™ brand has relaunched its flagship wellness product hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving. Also today, MCOA was featured in an article on the advancements of cannabidiol (CBD), an extract of the substance that can be used for a variety of medical applications.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0487, up 22.06%, on 137,995 volume with 58 trades. The average volume for the last 60 days is 139,716 and the stock's 52-week low/high is $0.3095/$0.71.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is growing its patent portfolio with two more patent grants in the U.S., predicting three more from Australia, and it is currently preparing new patent application filings as it projects more patent awards this year. It already has more than 40 patent applications or awards from more than 40 countries worldwide (

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.91, up 21.66%, on 1,088,344 volume with 1,340 trades. The average volume for the last 60 days is 182,953 and the stock's 52-week low/high is $0.27/$2.54.

Recent News


BLOCKStrain Technology Corp. (TSXV: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

ABATTIS BIOCEUTICALS CORP. (CSE:ATT; OTC:ATTBF) ("Abattis") and BLOCKSTRAIN TECHNOLOGY CORP. (TSXV: DNAX.V) ("BLOCKStrain") are pleased to announce that they have signed a letter of intent (the "LOI") to integrate BLOCKStrain's proprietary technology into Abattis's  product and services ecosystem. Through their collaboration, the parties hope to enable Abattis clients to instantly arrange for sales, shipping, testing and analysis of Abattis products and give clients comprehensive visibility over such products over their entire lifecycles.

BLOCKStrain Technology Corp. (TSX.V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.


BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.


BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.


BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.80, up 17.65%, on 994,340 volume. The stock's 52-week low/high is $0.10/$1.20.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") has today released a letter to shareholders from the Company's President and CEO, Trent Mell, to provide an update on the Company's business activities for the remainder of 2018. This letter is available on our website at Also today, NetworkNewsWire released a report on the company detailing how FTSSF is well-positioned as cobalt becomes increasingly important in powering technology, even as the U.S. government has identified it as a critical mineral for securing national interests.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.59, up 9.52%, on 644,933 volume with 249 trades. The average volume for the last 60 days is 117,645 and the stock's 52-week low/high is $0.375/$1.3041.

Recent News


PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that is has entered into an agreement with Stadnyk & Partners, whereby it has agreed to engage Stadnyk & Partners to provide strategic advisory services to the Company.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.0744, up 6.29%, on 51,800 volume with 17 trades. The average volume for the last 60 days is 18,656 and the stock's 52-week low/high is $0.002/$0.20.

Recent News


The Green Organic Dutchman (TSX: TGOD)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman Ltd. (TSX:TGOD) (the "Company" or "TGOD") is pleased to announce that it has entered into an engagement letter with Canaccord Genuity Corp., acting as co-lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including PI Financial Corp. as co-lead underwriter, and Mackie Research Capital Corporation (collectively, the "Underwriters") pursuant to which the Underwriters have agreed to purchase 3,910,000 special warrants of the Company (the "Special Warrants"), on an bought deal basis, at a price per Special Warrant of $6.40 for aggregate gross proceeds of approximately $25 million (the "Offering"). Closing of the Offering is expected to occur on June 26, 2018.

The Green Organic Dutchman (TSX: TGOD), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $7.69, up 10.01%, 8,670,000 volume. The stock's 52-week low/high is $3.50/$7.25.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, offers a report on the company’s presence at four recent cannabis expos held in Canada and the United States.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.736, up 5.14%, on 20,460 volume with 14 trades. The average volume for the last 60 days is 15,588 and the stock's 52-week low/high is $0.324/$1.62.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile (TSX.V:LITH) (OTC: LTMCF) was highlighted today in an article on the increasingly heated scramble for assets in the lithium space as EVs become more and more predominant in the vehicle market. Also today, NetworkNewsWire released a report on the company detailing how LTMCF may possibly have the largest upside of any lithium miner this year.

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.7417, up 0.41%, on 50,134 volume with 54 trades. The average volume for the last 60 days is 2,361 and the stock's 52-week low/high is $0.6587/$0.9021.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element Inc. (NASDAQ: NETE) was highlighted today by, which has assessed several Internet Software & Services equities and provided free research reports on them. To get the full research report on NETE

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.76, off by 1.31%, on 248,452 volume with 1,172 trades. The average volume for the last 60 days is 542,836 and the stock's 52-week low/high is $2.556/$33.51.

Recent News



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

As an established leader in cannabis testing in the United States and Canada, EVIO Inc. (OTCQB: EVIO) is more familiar than most with the knowns and unknowns of medical cannabis. The company is now maximizing its technical know-how and experience by expanding into the research and development of cannabis-based medicines.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.11, off by 1.77%, on 108,377 volume with 98 trades. The average volume for the last 60 days is 74,360 and the stock's 52-week low/high is $0.47/$2.70.

Recent News


Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout Inc. (OTCPink:GOHE) (“Global”) is pleased to announce that, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”), of which Global is a significant shareholder (currently 18% ownership), announced today that they have structured a reverse triangular merger agreement (the “Agreement”) with Global whereby MTRAC will be the post-merger operating entity.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0175, up 0.57%, on 3,494,479 volume with 11 trades. The average volume for the last 60 days is 8,760,141 and the stock's 52-week low/high is $0.0099/$0.16.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced that it has entered into a licensing partnership with The Bad Crypto Podcast to re-distribute the podcast's most popular interviews on , in Chinese.  

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.47, off by 3.69%, on 58,667 volume with 34 trades. The average volume for the last 60 days is 58,398 and the stock's 52-week low/high is $0.40/$1.58.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.